Back
Expedia Group Vs. Aligos Therapeutics Industry Stock Comparison
Buy
78
EXPE
Expedia Group
Last Price:
$180.23
Seasonality Move:
2.02%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$33.58
Seasonality Move:
-18.25%
Buy
78
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
-
The current Expedia Group [EXPE] share price is $182.62. The Score for EXPE is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
EXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.39. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $182.62The current trend is moderately bearish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.39The current trend is moderately bearish and ALGS is experiencing slight selling pressure.
EXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.97 | Buy |
Relative Strength Index (14 RSI): | 47.78 | Sell |
Chaikin Money Flow: | 541365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (181.94 - 189.42) | Sell |
Bollinger Bands (100): | (141.93 - 182.79) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.47 | Buy |
Relative Strength Index (14 RSI): | 56.78 | Buy |
Chaikin Money Flow: | -32589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.39 - 41.59) | Buy |
Bollinger Bands (100): | (6.9 - 29.68) | Buy |
EXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 185.04 | Sell |
20-day SMA: | 184.94 | Sell |
50-day SMA: | 180.57 | Buy |
200-day SMA: | 143.74 | Buy |
8-day EMA: | 184.53 | Sell |
20-day EMA: | 184.6 | Sell |
50-day EMA: | 178.32 | Buy |
200-day EMA: | 152.33 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.2 | Sell |
20-day SMA: | 38.15 | Buy |
50-day SMA: | 25.97 | Buy |
200-day SMA: | 17.23 | Buy |
8-day EMA: | 40.71 | Sell |
20-day EMA: | 37.37 | Buy |
50-day EMA: | 29.03 | Buy |
200-day EMA: | 19.88 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.26 per share, and an increase next year of $2.85 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Expedia Group Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |